PMPRB Updates: Definition of “Gap Medicine” amended, modified threshold for investigating the price of new patented medicines
By EsqSocial Corporation 05/04/21
Consultation results - On March 17, 2021 the Patented Medicine Prices Review Board (PMPRB) announced the result of the Consultation opened in January... regarding the definition of “Gap Medicine” and compliance timelines for Grandfathered and Gap Medicines. As proposed, the Guidelines will be amended such that a Gap Medicine will be defined as a medicine for which a Drug Identification Number (DIN) was assigned on or after August 21, 2019, and which was first sold in Canada by July 1, 2021....
By: Smart & Biggar